Patents by Inventor NANJING MOLECULAR RESEARCH, INC.

NANJING MOLECULAR RESEARCH, INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOUBLE-LIVER-TARGETING PHOSPHORAMIDATE AND PHOSPHONOAMIDATE PRODRUGS
    Publication number: 20130210757
    Abstract: This application discloses phosphoramidate and phosphonoamidate prodrugs of alcohol-based therapeutic agents, such as nucleosides, nucleotides, acyclonucleosides, C-nucleosides, and C-nucleotides, and use of these prodrugs for treatment of diseases or disorders, including infectious diseases and cancers. This application also discloses a general method for enhancing bioavailability and/or liver-targeting property of alcohol drugs through converting the alcohol drugs to phosphoramidate or phosphonoamidate prodrugs, and methods of preparation of these prodrugs.
    Type: Application
    Filed: March 15, 2013
    Publication date: August 15, 2013
    Applicant: NANJING MOLECULAR RESEARCH, INC.
    Inventor: NANJING MOLECULAR RESEARCH, INC.